12
Participants
Start Date
September 30, 2025
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2028
Tranexamic Acid Injectable Product
Participants will receive three doses of TXA 500 mg (5 mL of TXA 100mg/ml) nebulized using a PARI LC D Disposable Nebulizer or equivalent over 10-15 minutes using 8 or greater liter/minute of gas flow.
Normal Saline
Participants will receive three 5 ml doses of placebo (normal saline) nebulized using a PARI LC D Disposable Nebulizer or equivalent over 10-15 minutes using 8 or greater liter/minute of gas flow.
University Hospital, San Antonio
The University of Texas Health Science Center at San Antonio
OTHER